Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引：0
|
作者：
Zorn, Kristin K. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：738 / 740
页数：2
相关论文
共 50 条
  • [41] Carboplatin plus paclitaxel scheduling for advanced ovarian cancer Reply
    Pignata, Sandro
    Di Maio, Massimo
    Gallo, Ciro
    Perrone, Francesco
    LANCET ONCOLOGY, 2014, 15 (07): : E250 - E251
  • [42] Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with advanced ovarian cancer
    Yoshida, H.
    Sumi, T.
    Abe, K.
    Ishiko, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2009, 30 (05) : 583 - 585
  • [43] Population pharmacokinetc/pharmacodynamic modeling of paclitaxel and carboplatin in ovarian cancer
    Egorin, Merrill J.
    CLINICAL CANCER RESEARCH, 2008, 14 (08) : 2517 - 2517
  • [44] Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
    Pons, Daniel G.
    Sastre-Serra, Jorge
    Nadal-Serrano, Mercedes
    Oliver, Aina
    Garcia-Bonafe, Magdalena
    Bover, Isabel
    Roca, Pilar
    Oliver, Jordi
    ANTICANCER RESEARCH, 2012, 32 (11) : 4723 - 4728
  • [45] Paclitaxel (Taxol(R)) plus carboplatin as first-line treatment for advanced ovarian cancer
    Ozols, RF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 : 9 - 12
  • [46] Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report
    Mehmood, Faisal
    Touseef, Mumtaz
    Ashraf, Amna
    Rai, Izza Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (12) : 2184 - 2187
  • [47] CARBOPLATIN IN THE TREATMENT OF OVARIAN-CANCER
    ALBERTS, DS
    MASONLIDDIL, N
    SEMINARS IN ONCOLOGY, 1989, 16 (02) : 19 - 26
  • [48] The Combination of Weekly Carboplatin and Paclitaxel is Active and Tolerated for the Treatment of Advanced Ovarian Cancer in Elderly Patients
    Lugini, A.
    Pace, R.
    Capparella, V.
    Ciorra, A. A.
    Sciacca, V.
    Pistillucci, G.
    Rossi, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S538 - S538
  • [49] Weekly paclitaxel in advanced ovarian cancer: Salvage after paclitaxel failure and combination carboplatin
    Aghajanian, C
    Sabbatini, P
    Spriggs, D
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 99 - 99
  • [50] Cost effectiveness of bevacizumab plus carboplatin paclitaxel versus carboplatin paclitaxel as front line for advanced ovarian cancer in Thailand
    Katanyoo, Kanyarat
    Chaikledkaew, Usa
    Chandeying, Nutthaporn
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345